"Rift Valley Fever" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute infection caused by the RIFT VALLEY FEVER VIRUS, an RNA arthropod-borne virus, affecting domestic animals and humans. In animals, symptoms include HEPATITIS; abortion (ABORTION, VETERINARY); and DEATH. In humans, symptoms range from those of a flu-like disease to hemorrhagic fever, ENCEPHALITIS, or BLINDNESS.
| Descriptor ID |
D012295
|
| MeSH Number(s) |
C02.081.810 C02.407.810 C02.782.147.810 C02.782.417.762 C06.552.380.315.430.812 C22.467.435.812
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Rift Valley Fever".
Below are MeSH descriptors whose meaning is more specific than "Rift Valley Fever".
This graph shows the total number of publications written about "Rift Valley Fever" by people in this website by year, and whether "Rift Valley Fever" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rift Valley Fever" by people in Profiles.
-
Potent neutralizing human monoclonal antibodies protect from Rift Valley fever encephalitis. JCI Insight. 2024 Aug 01; 9(18).
-
A highly potent human neutralizing antibody prevents vertical transmission of Rift Valley fever virus in a rat model. Nat Commun. 2023 07 26; 14(1):4507.
-
Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease. Am J Trop Med Hyg. 2022 11 14; 107(5):1091-1098.
-
Arbovirus infections among laboratory personnel in Ibadan, Nigeria. Am J Trop Med Hyg. 1981 Jul; 30(4):855-61.